SignatureFD’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,021
| Closed | -$60K | – | 3283 |
|
|
2023
Q4 | $60K | Buy |
1,021
+444
| +77% | +$26.1K | ﹤0.01% | 1375 |
|
|
2023
Q3 | $25.1K | Buy |
577
+277
| +92% | +$12.1K | ﹤0.01% | 1735 |
|
|
2023
Q2 | $10.8K | Buy |
300
+64
| +27% | +$2.31K | ﹤0.01% | 2195 |
|
|
2023
Q1 | $8.77K | Sell |
236
-309
| -57% | -$11.5K | ﹤0.01% | 2273 |
|
|
2022
Q4 | $24.7K | Sell |
545
-804
| -60% | -$36.4K | ﹤0.01% | 1698 |
|
|
2022
Q3 | $94K | Buy |
1,349
+36
| +3% | +$2.51K | ﹤0.01% | 985 |
|
|
2022
Q2 | $88K | Buy |
1,313
+975
| +288% | +$65.3K | ﹤0.01% | 1038 |
|
|
2022
Q1 | $28K | Buy |
338
+171
| +102% | +$14.2K | ﹤0.01% | 1672 |
|
|
2021
Q4 | $24K | Buy |
167
+140
| +519% | +$20.1K | ﹤0.01% | 1715 |
|
|
2021
Q3 | $5K | Buy |
27
+3
| +13% | +$556 | ﹤0.01% | 2385 |
|
|
2021
Q2 | $4K | Buy |
24
+6
| +33% | +$1K | ﹤0.01% | 2391 |
|
|
2021
Q1 | $3K | Sell |
18
-16
| -47% | -$2.67K | ﹤0.01% | 2397 |
|
|
2020
Q4 | $7K | Buy |
34
+20
| +143% | +$4.12K | ﹤0.01% | 1859 |
|
|
2020
Q3 | $2K | Hold |
14
| – | – | ﹤0.01% | 2296 |
|
|
2020
Q2 | $2K | Buy |
+14
| New | +$2K | ﹤0.01% | 2206 |
|